Advancing Prime Editing–Based Genome Editing Technologies for Therapeutic Applications

November 30th, 2025|Categories: Past Webinars|

Date: March 26, 2026 Time: 12-1pm EDT / 5-6pm CET Title: Advancing Prime Editing–Based Genome Editing Technologies for Therapeutic Applications Description: In this webinar, I will discuss recent advances in prime editing–based genome engineering, including split prime editing, template-jumping prime editing, ...

Acute CNS Responses to centrally Delivered Oligonucleotides

November 30th, 2025|Categories: Past Webinars|

Date: January 29, 2026 Time: 11am-12pm EST / 5-6pm CET Title: Acute CNS Responses to centrally Delivered Oligonucleotides Description: Oligonucleotides delivered into cerebrospinal fluid elicit two independent, short-lived CNS phenotypes: an immediate neuronal activation phenotype that appears within minutes and resolves ...

BLADE Directed Evolution of SaCas9 gRNAs Improves Gene Editing Efficiency

October 14th, 2025|Categories: Past Webinars|

Date: December 11, 2025 Time: 11-12pm EST / 5-6pm CET Title: BLADE Directed Evolution of SaCas9 gRNAs Improves Gene Editing Efficiency Description: CRISPR-Cas9 efficiency is often limited by misfolding between the sgRNA scaffold and spacer regions. Using the BLADE-SELEX directed evolution ...

Trainee Spotlight Series: 2025 Oligo Meeting Poster Winners 1

October 14th, 2025|Categories: Past Webinars|

Date: December 4, 2025 Time: 11-12pm EST / 5-6pm CET Title: Enhancing mRNA Nuclease Resistance via Nucleobase-Mimicking Small Molecule Self-Assembly Description: Nucleic acid therapeutics offer high efficacy and specificity but suffer from instability, requiring ultra-low storage temperatures and degrading rapidly in ...

New Approaches for Functional Oligonucleotides: RNA Activation and Non-Nucleosidic Aptamers.

October 14th, 2025|Categories: Past Webinars|

Date: November 20, 2025 Time: 11-12pm EST / 5-6pm CET Title: New Approaches for Functional Oligonucleotides: RNA Activation and Non-Nucleosidic Aptamers Description: This talk will highlight two complementary approaches aimed at expanding the functional scope of oligonucleotide therapeutics. First, I will ...

Go to Top